Cross Country Healthcare, Inc. (NASDAQ:CCRN - Get Free Report) has been given an average rating of "Hold" by the five analysts that are presently covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $18.50.
A number of brokerages recently commented on CCRN. Barrington Research reduced their price objective on shares of Cross Country Healthcare from $21.00 to $19.00 and set an "outperform" rating for the company in a research report on Thursday, August 8th. Truist Financial reduced their price target on Cross Country Healthcare from $17.00 to $15.00 and set a "hold" rating for the company in a report on Monday, October 21st. Finally, Benchmark dropped their price objective on Cross Country Healthcare from $19.00 to $18.00 and set a "buy" rating on the stock in a report on Thursday, November 7th.
View Our Latest Report on CCRN
Institutional Trading of Cross Country Healthcare
Several large investors have recently bought and sold shares of the company. Truvestments Capital LLC purchased a new stake in shares of Cross Country Healthcare in the 3rd quarter worth about $39,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Cross Country Healthcare in the third quarter valued at about $49,000. nVerses Capital LLC acquired a new stake in shares of Cross Country Healthcare in the second quarter valued at approximately $50,000. Point72 DIFC Ltd purchased a new position in shares of Cross Country Healthcare during the 3rd quarter worth approximately $52,000. Finally, Gladius Capital Management LP raised its position in shares of Cross Country Healthcare by 83.4% during the 3rd quarter. Gladius Capital Management LP now owns 3,985 shares of the business services provider's stock worth $54,000 after purchasing an additional 1,812 shares during the last quarter. Institutional investors and hedge funds own 96.03% of the company's stock.
Cross Country Healthcare Stock Down 0.4 %
NASDAQ:CCRN traded down $0.04 during midday trading on Friday, reaching $10.34. The stock had a trading volume of 296,661 shares, compared to its average volume of 606,574. The stock has a market cap of $340.39 million, a P/E ratio of -206.76, a P/E/G ratio of 1.98 and a beta of 0.65. The firm has a fifty day simple moving average of $12.17 and a two-hundred day simple moving average of $13.87. Cross Country Healthcare has a 12-month low of $9.58 and a 12-month high of $23.64.
Cross Country Healthcare Company Profile
(
Get Free ReportCross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Further Reading
Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.